BMEA
Biomea Fusion Inc
NASDAQ: BMEA · HEALTHCARE · BIOTECHNOLOGY
$1.36
-6.21% today
Updated 2026-04-30
Market cap
$136.65M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$1 – $3
Volume
1.5M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$7.17
+427.21%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy5 Buy0 Hold0 Sell1 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-13.19M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-80.02M | $-117.25M | $-138.43M | $-61.80M | $4.61M |
| EPS | — | — | — | — | $-1.18 |
| Free cash flow | $-63.45M | $-99.96M | $-120.26M | $-70.37M | $-13.19M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Biomea Fusion Inc trades at $1.36. Our Smart Value Score of 21/100 indicates the stock is weak.
Frequently asked questions
What is Biomea Fusion Inc's stock price?
Biomea Fusion Inc (BMEA) trades at $1.36.
Is Biomea Fusion Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Biomea Fusion Inc (BMEA)?
The analyst target price is $7.17, representing +427.2% upside from the current price of $1.36.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-152.40%
Beta-0.27
50D MA$1.50
200D MA$1.54
Shares out0.07B
Float0.07B
Short ratio—
Avg volume1.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—